HSBC Holdings’s Dr. Reddy's Laboratories RDY Stock Holding History

HSBC Holdings’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-21,500	Closed	-$339K	–	3222
2024 Q4	$339K	Buy	21,500 +4,000	+23%	+$60.1K	﹤0.01%	2421
2024 Q3	$278K	Sell	17,500 -2,500	-13%	-$40.2K	﹤0.01%	2403
2024 Q2	$302K	Hold	20,000	–	–	﹤0.01%	2271
2024 Q1	$293K	Buy	+20,000	New	+$292K	﹤0.01%	2448
2023 Q4	–	Sell	-37,500	Closed	-$495K	–	2884
2023 Q3	$495K	Buy	+37,500	New	+$507K	﹤0.01%	1991
2015 Q3	–	Sell	-7,925	Closed	-$88K	–	2123
2015 Q2	$88K	Buy	+7,925	New	+$87.5K	﹤0.01%	1935

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

HSBC Holdings's RDY Position: Q2 2026 in Review

HSBC Holdings held its Dr. Reddy's Laboratories (RDY) position steady in Q2 2026 at 78,293 shares worth $1.13M. The position accounts for ﹤0.01% of the portfolio, ranked #1874.

HSBC Holdings first reported a position in RDY in Q2 2013 and has held it in 53 quarters since. The position peaked at $28.8M in Q4 2016. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

HSBC Holdings held 78,293 shares of Dr. Reddy's Laboratories worth $1.13M as of Q2 2026.
HSBC Holdings left its Dr. Reddy's Laboratories share count unchanged in Q2 2026.
Dr. Reddy's Laboratories made up ﹤0.01% of HSBC Holdings's portfolio in Q2 2026, its #1874 holding.
HSBC Holdings first reported a position in Dr. Reddy's Laboratories in Q2 2013 and has held it in 53 quarters since.
HSBC Holdings's Dr. Reddy's Laboratories position peaked at $28.8M in Q4 2016.
238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.